0001209191-22-024064.txt : 20220411 0001209191-22-024064.hdr.sgml : 20220411 20220411200221 ACCESSION NUMBER: 0001209191-22-024064 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220407 FILED AS OF DATE: 20220411 DATE AS OF CHANGE: 20220411 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kihara James CENTRAL INDEX KEY: 0001816160 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50768 FILM NUMBER: 22820903 MAIL ADDRESS: STREET 1: C/O ACADIA PHARMACEUTICALS INC. STREET 2: 12830 EL CAMINO REAL, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 061376651 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-558-2871 MAIL ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-04-07 0 0001070494 ACADIA PHARMACEUTICALS INC ACAD 0001816160 Kihara James C/O ACADIA PHARMACEUTICALS, INC. 12830 EL CAMINO REAL, SUITE 400 SAN DIEGO CA 92130 0 1 0 0 Principal Accounting Officer Common Stock 2022-04-07 4 M 0 2977 A 3458 D Common Stock 2022-04-08 4 S 0 1025 27.05 D 2433 D Restricted Stock Units 2022-04-07 4 M 0 2977 0.00 D Common Stock 2977 2978 D Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock. The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units. 50% of the restricted stock units vest on April 7, 2022 and 25% vest on each of April 7, 2023 and April 7, 2024. /s/ Austin D. Kim, Attorney-in-Fact 2022-04-11